The Faculty Core Facilities provides centralized platform technologies and expertise support on high resolution imaging and high throughput flow cytometry. It is a training and development centre for advanced imaging and cell sorting technologies, promotes and facilitates multi-disciplinary research studies and collaboration among researchers within and outside the Faculty of Medicine.
The Centre for PanorOmic Sciences (CPOS) provides researchers with cutting-edge core technological platforms and technological support/services in particular on multi-omics big data (genomics, transcriptomics, epigenomics, metabolomics, proteomics and microbiomics).
The Proteomics and Metabolomics Core Facility (PMCore) was established with a generous donation from The Hongkong and Shanghai Banking Corporation Limited (HSBC). The facility is equipped with state-of-the-art instrumentations that offer a wide range of high resolution and high mass accuracy mass spectrometry-based analytical capabilities. The PMCore provides routine and customized proteomics and metabolomics services by well-trained technical specialists.
The Laboratory Animal Unit (LAU), established in 1979, serves the primary function of breeding specific pathogen free laboratory animals for research and teaching and provides centralised animal holding and surgical facilities for biomedical research. It also provides advice and services in relation to laboratory animal science and veterinary. The LAU was awarded full accreditation status by AAALAC International (Association for Assessment and Accreditation of Laboratory Animal Care International) in 2004.
The Transgenic core facility (TCF), being a part of the Laboratory Animal Unit, supports the Faculty and the University in research by not only preserving valuable transgenic mouse lines through embryo/sperm cryopreservation, and re-derivation and rescue of mouse colonies using assisted reproductive technology; but also generating novel transgenic and gene targeted mice for researchers to study various disease models. The facility also maintains a repository of reagent mouse lines for principal investigators to generate mutant/transgenic mice in research to study disease pathogenesis and gene interaction in vivo. The mission of TCF is to provide an efficient centralized service to support the University's cutting-edge research using genetically modified animals.
The Clinical Trials Centre (CTC) founded in 1998 serves the central platform for management and coordination of clinical studies under the University HKU and its affiliated teaching hospital, Queen Mary Hospital. It is devoted to partnering with clinical investigators, research organisations and the healthcare industry in advancing human healthcare by promoting, attracting and facilitating clinical studies.